OpenURL Connection Search

Select item for more details and to access through your institution.

Cost of lung cancer: a methodological review.
Published in:
2006
By:
- Molinier, Laurent;
- Combescure, Christophe;
- Chouaîd, Cristos;
- Daurès, Jean-Pierre;
- Housset, Bruno;
- Fabre, Didier;
- Grand, Alain;
- Vergnenègre, Alain;
- Chouaïd, Cristos;
- Daurès, Jean-Pierre;
- Vergnenègre, Alain
Publication type:
journal article
Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504).
Published in:
2012
By:
- Christos, Chouaid;
- Hervé, Le Caer;
- Chrystelle, Locher;
- Cecile, Dujon;
- Pascal, Thomas;
- Jean Bernard, Auliac;
- Isabelle, Monnet;
- Alain, Vergnenegre;
- and GFPC 0504 Team;
- Chouaid, Christos;
- Le Caer, Hervé;
- Locher, Chrystelle;
- Dujon, Cecile;
- Thomas, Pascal;
- Auliac, Jean Bernard;
- Monnet, Isabelle;
- Vergnenegre, Alain;
- GFPC 0504 Team
Publication type:
journal article
First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers.
Published in:
Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 441, doi. 10.1007/s00432-019-03070-3
By:
- Landre, Thierry;
- Des Guetz, Gaetan;
- Chouahnia, Kader;
- Taleb, Cherifa;
- Vergnenègre, Alain;
- Chouaïd, Christos
Publication type:
Article
Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.
Published in:
2016
By:
- Touati, Mohamed;
- Lamarsalle, Ludovic;
- Moreau, Stéphane;
- Vergnenègre, Françoise;
- Lefort, Sophie;
- Brillat, Catherine;
- Jeannet, Laetitia;
- Lagarde, Aline;
- Daulange, Annick;
- Jaccard, Arnaud;
- Vergnenègre, Alain;
- Bordessoule, Dominique
Publication type:
journal article
Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax Risk.
Published in:
International Journal of COPD, 2021, v. 16, p. 1957, doi. 10.2147/COPD.S307829
By:
- Egenod, Thomas;
- Tricard, Jeremy;
- Fumat, Romane;
- Simonneau, Yannick;
- Favard, Florent;
- Guillot, Marc-Samir;
- Collot, Samia;
- Dupuis, Marion;
- Melloni, Boris;
- Vergnenegre, Alain;
- Guibert, Nicolas;
- Dusselier, Matthieu
Publication type:
Article
Cost Analysis of Erlotinib Versus Chemotherapy for First-Line Treatment of Non-Small-Cell Lung Cancer in Frail Elderly Patients Participating in a Prospective Phase 2 Study (GFPC 0505)
Published in:
2013
By:
- Chouaid, Christos;
- Le Caer, Hervé;
- Corre, Romain;
- Crequit, Jacquy;
- Locher, Chrystelle;
- Falchero, Lionel;
- Dujon, Cecile;
- Berard, Henri;
- Monnet, Isabelle;
- Vergnenegre, Alain
Publication type:
Journal Article
Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006983
By:
- Monnet, Isabelle;
- Vergnenègre, Alain;
- Robinet, Gilles;
- Berard, Henri;
- Lamy, Regine;
- Falchero, Lionel;
- Vieillot, Sabine;
- Schott, Roland;
- Ricordel, Charles;
- Chouabe, Stephane;
- Thomas, Pascal;
- Gervais, Radj;
- Madroszyk, Anne;
- Abdiche, Samir;
- Chiappa, Anne Marie;
- Greillier, Laurent;
- Decroisette, Chantal;
- Auliac, Jean Bernard.;
- Chouaïd, Christos
Publication type:
Article
Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006983
By:
- Monnet, Isabelle;
- Vergnenègre, Alain;
- Robinet, Gilles;
- Berard, Henri;
- Lamy, Regine;
- Falchero, Lionel;
- Vieillot, Sabine;
- Schott, Roland;
- Ricordel, Charles;
- Chouabe, Stephane;
- Thomas, Pascal;
- Gervais, Radj;
- Madroszyk, Anne;
- Abdiche, Samir;
- Chiappa, Anne Marie;
- Greillier, Laurent;
- Decroisette, Chantal;
- Auliac, Jean Bernard.;
- Chouaïd, Christos
Publication type:
Article
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.
Published in:
2016
By:
- Bonanno, Laura;
- Costa, Carlota;
- Majem, Margarita;
- Sanchez, Jose-Javier;
- Rodriguez, Ignacio;
- Gimenez-Capitan, Ana;
- Molina-Vila, Miquel Angel;
- Vergnenegre, Alain;
- Massuti, Bartomeu;
- Favaretto, Adolfo;
- Rugge, Massimo;
- Pallares, Cinta;
- Taron, Miquel;
- Rosell, Rafael
Publication type:
journal article
A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective.
Published in:
Interactive Cardiovascular & Thoracic Surgery, 2015, v. 20, n. 6, p. 783, doi. 10.1093/icvts/ivv050
By:
- Barlesi, Fabrice;
- Chouaid, Christos;
- Crequit, Jacky;
- Le Caer, Hervé;
- Pujol, Jean-Louis;
- Legodec, Julien;
- Vergnenegre, Alain;
- Le Treut, Jacques;
- Fabre-Guillevin, Elizabeth;
- Loundou, Anderson;
- Auquier, Pascal;
- Simeoni, Marie-Claude;
- Thomas, Pascal A.
Publication type:
Article
Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04).
Published in:
Cancer Medicine, 2020, v. 9, n. 2, p. 432, doi. 10.1002/cam4.2716
By:
- Vergnenegre, Alain;
- Geier, Margaux;
- Guisier, Florian;
- Lamy, Regine;
- Comet, Bénédicte;
- Le Garff, Gwenaelle;
- Do, Pascal;
- Janicot, Henri;
- Morel, Hugues;
- Decroisette, Chantal;
- Andre, Michel;
- Falchero, Lionel;
- Paleiron, Nicolas;
- Monnet, Isabelle
Publication type:
Article
Economics of Treatments for Non-Small Cell Lung Cancer.
Published in:
PharmacoEconomics, 2009, v. 27, n. 2, p. 113, doi. 10.2165/00019053-200927020-00003
By:
- Chouaid, Christos;
- Atsou, Kukovi;
- Hejblum, Gilles;
- Vergnenegre, Alain
Publication type:
Article
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Published in:
Cancer Management & Research, 2019, v. 11, p. 10821, doi. 10.2147/CMAR.S219984
By:
- Vergnenègre, Alain;
- Basse, Victor;
- Garff, Gwenaelle Le;
- Bylicki, Olivier;
- Dubos-Arvis, Catherine;
- Comet, Bénédicte;
- Marcq, Marie;
- Treut, Jacques Le;
- Auliac, Jean-Bernard;
- Madroszyk, Anne;
- Fraboulet, Gislaine;
- Crequit, Jacky;
- Thomas, Pascal;
- Paleiron, Nicolas;
- Monnet, Isabelle
Publication type:
Article
Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer.
Published in:
2019
By:
- Auliac, Jean-Bernard;
- Saboundji, Karima;
- Andre, Michel;
- Madelaine, Jeannick;
- Quere, Gilles;
- Masson, Philippe;
- Vergnenegre, Alain;
- Lamy, Régine;
- Raymond, Stéphane;
- Chiappa, Anne-Marie;
- Hauss, Pierre-Alexandre;
- Fournel, Pierre;
- Corre, Romain;
- Chouaid, Christos
Publication type:
journal article
Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study).
Published in:
2017
By:
- Auliac, Jean-Bernard;
- Monnet, Isabelle;
- Dubos-Arvis, Catherine;
- Chiappa, Anne;
- Baize, Nathalie;
- Bota, Suzana;
- Vergnenegre, Alain;
- Doubre, Helene;
- Locher, Chrystele;
- Bizieux, Acya;
- Robinet, Gilles;
- Chouaid, Christos;
- Chiappa, Anne Marie
Publication type:
journal article
Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer.
Published in:
2017
By:
- Bylicki, Olivier;
- Paleiron, Nicolas;
- Margery, Jacques;
- Guisier, Florian;
- Vergnenegre, Alain;
- Robinet, Gilles;
- Auliac, Jean-Bernard;
- Gervais, Radj;
- Chouaid, Christos
Publication type:
journal article
Pharmacogenetics in lung cancer for the lay doctor.
Published in:
Targeted Oncology, 2008, v. 3, n. 3, p. 161, doi. 10.1007/s11523-008-0083-8
By:
- Rosell, Rafael;
- Vergnenegre, Alain;
- Fournel, Pierre;
- Massuti, Bartomeu;
- Camps, Carlos;
- Isla, Dolores;
- Sanchez, Jose;
- Moran, Teresa;
- Sirera, Rafael;
- Taron, Miquel
Publication type:
Article
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1104659
By:
- Pinet, Sandra;
- Durand, Stephanie;
- Perani, Alexandre;
- Darnaud, Lea;
- Amadjikpe, Fifame;
- Yon, Mathieu;
- Darbas, Tiffany;
- Vergnenegre, Alain;
- Egenod, Thomas;
- Simonneau, Yannick;
- Le Brun-Ly, Valerie;
- Pestre, Julia;
- Venat, Laurence;
- Thuillier, Frederic;
- Chaunavel, Alain;
- Duchesne, Mathilde;
- Fermeaux, Veronique;
- Guyot, Anne;
- Lacorre, Sylvain;
- Bessette, Barbara
Publication type:
Article
Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers.
Published in:
PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0219060
By:
- Dusselier, Matthieu;
- Deluche, Elise;
- Delacourt, Nellie;
- Ballouhey, Julia;
- Egenod, Thomas;
- Melloni, Boris;
- Vergnenègre, Charlotte;
- Veillon, Rémi;
- Vergnenègre, Alain
Publication type:
Article
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin--gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
Published in:
BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-953
By:
- Borget, Isabelle;
- Pérol, Maurice;
- Pérol, David;
- Lavolé, Armelle;
- Greillier, Laurent;
- Dô, Pascal;
- Westeel, Virginie;
- Crequit, Jacky;
- Poudenx, Michel;
- Vaylet, Fabien;
- Chabaud, Sylvie;
- Vergnenegre, Alain;
- Zalcman, Gérard;
- Chouaïd, Christos
Publication type:
Article
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
Published in:
2017
By:
- Chaib, Imane;
- Karachaliou, Niki;
- Pilotto, Sara;
- Servat, Jordi Codony;
- Xueting Cai;
- Xuefei Li;
- Drozdowskyj, Ana;
- Servat, Carles Codony;
- Jie Yang;
- Chunping Hu;
- Cardona, Andres Felipe;
- Vivanco, Guillermo Lopez;
- Vergnenegre, Alain;
- Sanchez, Jose Miguel;
- Provencio, Mariano;
- Reguart, Noemi;
- Caicun Zhou;
- Peng Cao;
- Ma, Patrick C.;
- Bivona, Trever G.
Publication type:
journal article
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review.
Published in:
ClinicoEconomics & Outcomes Research, 2015, v. 7, p. 9, doi. 10.2147/CEOR.S43328
By:
- Chouaïd, Christos;
- Crequit, Perinne;
- Borget, Isabelle;
- Vergnenegre, Alain
Publication type:
Article
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
Published in:
2014
By:
- Borget, Isabelle;
- Pérol, Maurice;
- Pérol, David;
- Lavolé, Armelle;
- Greillier, Laurent;
- Dô, Pascal;
- Westeel, Virginie;
- Crequit, Jacky;
- Léna, Hervé;
- Monnet, Isabelle;
- Le Caer, Hervé;
- Fournel, Pierre;
- Falchero, Lionel;
- Poudenx, Michel;
- Vaylet, Fabien;
- Chabaud, Sylvie;
- Vergnenegre, Alain;
- Zalcman, Gérard;
- Chouaïd, Christos;
- IFCT-GFPC investigators
Publication type:
journal article
Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504).
Published in:
BMC Cancer, 2012, v. 12, n. 1, p. 301, doi. 10.1186/1471-2407-12-301
By:
- Christos, Chouaid;
- Hervé, Le Caer;
- Chrystelle, Locher;
- Cecile, Dujon;
- Pascal, Thomas;
- Bernard, Auliac Jean;
- Isabelle, Monnet;
- Alain, Vergnenegre
Publication type:
Article

Found: 24